Cargando…
Generation of hematopoietic stem/progenitor cells with sickle cell mutation from induced pluripotent stem cell in serum-free system
INTRODUCTION: Sickle cell disease (SCD) is a monogenic disease and it is estimated that 300,000 infants are born annually with it. Most treatments available are only palliative, whereas the allogeneic hematopoietic stem cell transplantation offers the only potential cure for SCD. OBJECTIVE: Generati...
Autores principales: | Paes, Bárbara C.M.F., Stabeli, Luiza C.J.R., Costa, Péricles N.M., Orellana, Maristela Delgado, Kashima, Simone, Covas, Dimas Tadeu, Picanço-Castro, Virgínia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Hematologia e Hemoterapia
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8211631/ https://www.ncbi.nlm.nih.gov/pubmed/32229108 http://dx.doi.org/10.1016/j.htct.2020.01.005 |
Ejemplares similares
-
Induced Pluripotent Stem Cell for the Study and Treatment of Sickle Cell Anemia
por: Junqueira Reis, Luiza Cunha, et al.
Publicado: (2017) -
HTLV-1 affects the adipogenic differentiation of human mesenchymal stem cells
por: Rodrigues, Evandra Strazza, et al.
Publicado: (2011) -
Mobilizing hematopoietic progenitor cells in donors with sickle cell trait is safe
por: De Santis, Gil Cunha, et al.
Publicado: (2019) -
Generation of induced pluripotent stem cells from large domestic animals
por: Bressan, Fabiana Fernandes, et al.
Publicado: (2020) -
HTLV-1 infection in bone marrow mesenchymal stem cells isolated from HTLV-1 individuals
por: Rodrigues, Evandra Strazza, et al.
Publicado: (2014)